<--- Back to Details
First PageDocument Content
Gynaecological cancer / Vaccines / Cancer screening / Viral diseases / Human papillomavirus / Cervical cancer / HPV vaccine / Cervix / Colposcopy / Medicine / Papillomavirus / Oncology
Date: 2010-11-09 05:42:06
Gynaecological cancer
Vaccines
Cancer screening
Viral diseases
Human papillomavirus
Cervical cancer
HPV vaccine
Cervix
Colposcopy
Medicine
Papillomavirus
Oncology

Conclusions From ACCP Clinical Research in Developing Countries

Add to Reading List

Source URL: screening.iarc.fr

Download Document from Source Website

File Size: 87,17 KB

Share Document on Facebook

Similar Documents

Cancer / Clinical medicine / Health / Infectious causes of cancer / Papillomavirus / RTT / Gynaecological cancer / Vaccines / Human papillomavirus infection / HPV vaccines / Gardasil / Wart

INTRODUCTION Anogenital human papillomavirus (HPV) infections are nearly ubiquitous among sexually active individuals: data indicate that up to 80% of sexually active persons experience one or more anogenital HPV infect

DocID: 1rtdm - View Document

RTT / Gynaecological cancer / Gynaecology / Ovarian cancer

Elvira Ann Marano August 20, October 27, 2010

DocID: 1rpU4 - View Document

Cancer / RTT / Health / Clinical medicine / Infectious causes of cancer / Papillomavirus / Gynaecological cancer / Carcinogens / Human papillomavirus infection / Cervix / N.E.D. / Ovarian cancer

PDF Document

DocID: 1rmwK - View Document

Medicine / Clinical medicine / Cancer / RTT / Infectious causes of cancer / Cancer screening / Gynaecological cancer / Sexually transmitted diseases and infections / Cervical cancer / Fecal occult blood / Preventive healthcare / HPV vaccines

Be Healthy Wellness Benefits Be Healthy–

DocID: 1rifu - View Document

Cancer / Clinical medicine / Health / Infectious causes of cancer / RTT / Papillomavirus / Gynaecological cancer / Vaccines / Cervical cancer / HPV vaccines / Human papillomavirus infection / Cancer screening

Invited Speaker Seminar Title: Combining decision modeling and epidemiologic studies to determine optimal cervical cancer control policies in the era of HPV vaccines. Speaker: Shalini Kulasingam, PhD Host: Prof David Mat

DocID: 1re0N - View Document